A Parkinson's diagnosis — whether it came after months of subtle symptoms or following a GP referral — changes your relationship with the healthcare system. Here is what you need to know about your medical aid entitlements and how to protect them.
Does My Medical Aid Have to Cover This?
Yes. Parkinson's disease is a Chronic Disease List (CDL) condition. Your scheme must fund CDL-registered medications for Parkinson's disease indefinitely. This is a legislated obligation — it does not depend on your plan tier, and the medications cannot be restricted to your medical savings account once you are CDL-registered.
Register for CDL Now
Contact your scheme's chronic benefits department and register your diagnosis. You will need: - A neurologist's or physician's letter confirming Parkinson's disease (ICD-10: G20) - The scheme's CDL registration form
Once registered, your levodopa/carbidopa, dopamine agonists, and adjunct medications are funded from the CDL benefit — not your savings account. This is a tangible financial benefit that takes effect from the date the registration is approved.
Which Medications Are Covered?
CDL-funded (after registration): Levodopa/carbidopa (Sinemet), dopamine agonists (pramipexole, ropinirole), MAO-B inhibitors (rasagiline, selegiline), and COMT inhibitors (entacapone) are typically on CDL formularies.
May require exceptional-needs: The rotigotine transdermal patch (Neupro) and some extended-release formulations may require motivation if not on the standard CDL formulary. Ask your neurologist whether an exceptional-needs application is warranted.
Advanced therapy infusions (Duodopa, apomorphine pump): These are not standard CDL benefits and require specialist pre-authorisation through an advanced therapy pathway. Your neurologist will initiate this process if indicated.
The Neurologist Visit: What Your Scheme Owes You
Your scheme must fund neurologist consultations for CDL-registered Parkinson's disease. However, the frequency covered and the tariff at which they are funded matters: - Some plans cap specialist visits (e.g., 3–4 per year); if your neurologist wants to see you more frequently, additional visits may not be covered. - Neurologists in SA private practice commonly bill above medical aid tariff. Your gap cover pays the shortfall.
As your disease progresses and visit frequency increases, gap cover becomes more important. Confirm your gap cover OPL (~R220,000/year) and whether it covers outpatient specialist consultations (most do).
Deep Brain Stimulation: Planning the Conversation With Your Scheme
DBS is not for everyone — it is indicated for patients with motor fluctuations and dyskinesias that are no longer well-controlled on optimal oral therapy, typically after 5–10 years of disease. If your neurologist raises the possibility:
- Obtain a written clinical assessment from the neurologist with Hoehn & Yahr staging and UPDRS scores — this is the basis of the pre-authorisation motivation.
- Contact your scheme's case management line before any assessment at a DBS centre. Establish whether DBS is covered under your plan, and whether you need to use a designated DBS centre.
- Confirm pre-authorisation for both the surgical procedure and the DBS device (they are funded separately).
- Ask about the neurosurgeon's billing rate. Specialist shortfall on DBS implantation can reach R30,000–R80,000.
Physiotherapy, Occupational Therapy, and Speech Therapy
These allied health services are essential in Parkinson's disease management. Coverage varies widely: - Physiotherapy: Most plans have a physiotherapy benefit (often 10–20 visits/year). For Parkinson's, this is frequently insufficient. Ask your scheme whether an extended physiotherapy benefit is available with a chronic disease motivation. - Speech therapy: If dysphagia or dysarthria develops, a speech therapist assessment is medically important. Confirm your plan's speech therapy limit. - Occupational therapy: Home safety assessment and adaptive equipment planning are particularly important in falls-risk patients.
Practical Checklist: The Next Three Months
| Action | Priority |
|---|---|
| Register for CDL benefit (ICD-10: G20) | Immediate |
| Confirm medications are processed under CDL, not MSA | Within 2 weeks |
| Ask neurologist about rotigotine or extended-release formulations — exceptional-needs needed? | At next appointment |
| Check physiotherapy, speech therapy, and OT benefit limits | This week |
| Confirm gap cover status and OPL | This week |
| Ask neurologist about disease management programme availability | At next appointment |
What to Expect From Your Neurologist Relationship
Parkinson's disease is a lifelong condition requiring ongoing specialist input. In early disease, neurologist visits are typically every 3–6 months. In mid-to-late disease, visits may be every 1–3 months as medication adjustments become more frequent. The cumulative specialist consultation cost over years — and the shortfall above medical aid tariff — makes gap cover progressively more important as the disease advances.
Keep a symptom diary to bring to each neurologist appointment. Documenting motor fluctuations (times of day when medication is working versus wearing off), fall frequency, and non-motor symptoms gives your neurologist the information needed to adjust therapy accurately — and ensures the clinical record supports any future exceptional-needs applications.
Carers and Family: The Hidden Dimension
Parkinson's disease is managed not just by the patient but by a network of family members and carers. As the disease progresses, caregiver burden increases substantially. The Parkinson's Association of South Africa (PASA) offers caregiver support resources and information evenings. PASA support groups are available in major centres and are invaluable for both patients and families navigating the condition for the first time.
Support Resources
Parkinson's Association of South Africa (PASA): 011 787 8792 | www.parkinsons.co.za Support groups, patient information, caregiver resources
Parkinson's Community SA: Patient network and advocacy
Talk to Eldon
Get help understanding your plan options →
This page is general information about medical schemes. It is not medical advice: speak to a healthcare professional about your own treatment. Medical aid and gap cover advice is given by Eldon de Waal, a Supervised Representative of Approach Administration (FSP 23579).